Trials / Completed
CompletedNCT00676585
Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest
Corticosteroids Therapy in Refractory Shock Following Cardiac Arrest
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The major goal of this project is to determine whether the use of physiologic doses of corticosteroids will decrease time to shock reversal, alters the inflammatory cascade, and alters microcirculatory flow in post-cardiac arrest patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Normal Saline | Normal Saline |
| DRUG | Hydrocortisone | Hydrocortisone 100mg |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2008-05-13
- Last updated
- 2017-05-17
- Results posted
- 2017-05-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00676585. Inclusion in this directory is not an endorsement.